Silence Therapeutics Plc - Amer - stock earnings

SLN Quarterly earnings

DateEarningsRevenue
2023Q3 -10.1 million USD 3.4 million USD
2023Q2 -13.1 million USD 11.5 million USD
2023Q1 -12.6 million USD 14.1 million USD
2022Q4 -16.7 million USD 5.8 million USD
2022Q3 -7.9 million USD 3.7 million USD
2022Q2 -14.5 million USD 4.4 million USD
2022Q1 -10.1 million USD 7.5 million USD
2021Q4 -12.8 million USD 4.6 million USD
2021Q3 -13.4 million USD 4.3 million USD
2021Q2 -16.1 million USD 3.7 million USD
2021Q1 -11.6 million USD 4.3 million USD
2020Q4 -2.7 million USD -1.2 million USD
2020Q3 -11.7 million USD 2.6 million USD
2020Q2 -6.8 million USD 710172 USD
2020Q1 ? USD 709018 USD

SLN Yearly earnings

DateEarningsRevenue
2023 -54.3 million USD 35.7 million USD
2022 -49.0 million USD 21.2 million USD
2021 -53.3 million USD 16.8 million USD
2020 -44.5 million USD 7.5 million USD
2019 -25.7 million USD 319944 USD
2018 -23.4 million USD ? USD
2017 -2.2 million USD 21509 USD
2016 -10.4 million USD 950312 USD
2015 -9.8 million USD ? USD
2014 -17.3 million USD 23355 USD
2013 -14.8 million USD 192997 USD
2012 -42.6 million USD 264399 USD
2011 -8.8 million USD 1.1 million USD
2010 -13.6 million USD 3.7 million USD
2009 -12.1 million USD 2.8 million USD
2008 -10.9 million USD 3.2 million USD
2007 -10.1 million USD 8.0 million USD
2006 -7.5 million USD 3.8 million USD
2005 -6.2 million USD 877303 USD
2004 -5.7 million USD 305595 USD
2003 -4.1 million USD 2.4 million USD
2002 -2.4 million USD 1.9 million USD
2001 -3.2 million USD 198789 USD
2000 -2.9 million USD 1.4 million USD
1999 -3.5 million USD 2.2 million USD
1998 -2.0 million USD 265228 USD
1997 -2.2 million USD ? USD
1996 -1.2 million USD ? USD
1995 -1.1 million USD ? USD

SLN

Price: $23

52 week price:
4.55
27.72

Earnings Per Share: -1.47 USD

P/E Ratio: -14.03

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 18800

Market Capitalization: 1.2 billion

Links: